These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 17223592

  • 1. Osteonecrosis of the jaws associated with use of risedronate: report of 2 new cases.
    Brooks JK, Gilson AJ, Sindler AJ, Ashman SG, Schwartz KG, Nikitakis NG.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Jun; 103(6):780-6. PubMed ID: 17223592
    [Abstract] [Full Text] [Related]

  • 2. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
    Pazianas M, Miller P, Blumentals WA, Bernal M, Kothawala P.
    Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
    [Abstract] [Full Text] [Related]

  • 3. Clinical investigation of C-terminal cross-linking telopeptide test in prevention and management of bisphosphonate-associated osteonecrosis of the jaws.
    Kunchur R, Need A, Hughes T, Goss A.
    J Oral Maxillofac Surg; 2009 Jun; 67(6):1167-73. PubMed ID: 19446200
    [Abstract] [Full Text] [Related]

  • 4. Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia.
    Mavrokokki T, Cheng A, Stein B, Goss A.
    J Oral Maxillofac Surg; 2007 Mar; 65(3):415-23. PubMed ID: 17307586
    [Abstract] [Full Text] [Related]

  • 5. Osteonecrosis associated with short-term oral administration of bisphosphonate.
    Takagi Y, Sumi Y, Harada A.
    J Prosthet Dent; 2009 May; 101(5):289-92. PubMed ID: 19410063
    [Abstract] [Full Text] [Related]

  • 6. Osteonecrosis of the jaw in patients receiving intravenous or oral bisphosphonates.
    King AE, Umland EM.
    Pharmacotherapy; 2008 May; 28(5):667-77. PubMed ID: 18447663
    [Abstract] [Full Text] [Related]

  • 7. Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases.
    Grant BT, Amenedo C, Freeman K, Kraut RA.
    J Oral Maxillofac Surg; 2008 Feb; 66(2):223-30. PubMed ID: 18201600
    [Abstract] [Full Text] [Related]

  • 8. Bisphosphonate-associated osteonecrosis: a clinician's reference to patient management.
    Grewal VS, Fayans EP.
    Todays FDA; 2008 Aug; 20(8):38-41, 43-6. PubMed ID: 18767452
    [Abstract] [Full Text] [Related]

  • 9. Prevalence and risk factors of bisphosphonate-associated osteonecrosis of the jaw in prostate cancer patients with advanced disease treated with zoledronate.
    Walter C, Al-Nawas B, Grötz KA, Thomas C, Thüroff JW, Zinser V, Gamm H, Beck J, Wagner W.
    Eur Urol; 2008 Nov; 54(5):1066-72. PubMed ID: 18602738
    [Abstract] [Full Text] [Related]

  • 10. The nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in dental implant patients: a South Australian case series.
    Goss A, Bartold M, Sambrook P, Hawker P.
    J Oral Maxillofac Surg; 2010 Feb; 68(2):337-43. PubMed ID: 20116705
    [Abstract] [Full Text] [Related]

  • 11. Safety of oral bisphosphonates: controlled studies on alveolar bone.
    Jeffcoat MK.
    Int J Oral Maxillofac Implants; 2006 Feb; 21(3):349-53. PubMed ID: 16796276
    [Abstract] [Full Text] [Related]

  • 12. [Bisphosphonates and osteonecrosis of the jaws].
    Urade M.
    Clin Calcium; 2007 Feb; 17(2):241-8. PubMed ID: 17272882
    [Abstract] [Full Text] [Related]

  • 13. Treating low- and medium-potency bisphosphonate-related osteonecrosis of the jaws with a protocol for the treatment of chronic suppurative osteomyelitis: report of 7 cases.
    Alons K, Kuijpers SC, de Jong E, van Merkesteyn JP.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Feb; 107(2):e1-7. PubMed ID: 19071040
    [Abstract] [Full Text] [Related]

  • 14. "Bis-phossy jaws" - high and low risk factors for bisphosphonate-induced osteonecrosis of the jaw.
    Abu-Id MH, Warnke PH, Gottschalk J, Springer I, Wiltfang J, Acil Y, Russo PA, Kreusch T.
    J Craniomaxillofac Surg; 2008 Mar; 36(2):95-103. PubMed ID: 18234504
    [Abstract] [Full Text] [Related]

  • 15. Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment.
    Marx RE, Cillo JE, Ulloa JJ.
    J Oral Maxillofac Surg; 2007 Dec; 65(12):2397-410. PubMed ID: 18022461
    [Abstract] [Full Text] [Related]

  • 16. Bisphosphonate-related osteonecrosis of the jaws: a single-center study of 101 patients.
    Lazarovici TS, Yahalom R, Taicher S, Elad S, Hardan I, Yarom N.
    J Oral Maxillofac Surg; 2009 Apr; 67(4):850-5. PubMed ID: 19304045
    [Abstract] [Full Text] [Related]

  • 17. Incidence of bisphosphonate-associated osteonecrosis of the jaws in breast cancer patients.
    Walter C, Al-Nawas B, du Bois A, Buch L, Harter P, Grötz KA.
    Cancer; 2009 Apr 15; 115(8):1631-7. PubMed ID: 19156913
    [Abstract] [Full Text] [Related]

  • 18. Bisphosphonate-associated osteonecrosis of the jaws: the limits of a conservative approach.
    Tirelli G, Biasotto M, Chiandussi S, Dore F, De Nardi E, Di Lenarda R.
    Head Neck; 2009 Sep 15; 31(9):1249-54. PubMed ID: 19260132
    [Abstract] [Full Text] [Related]

  • 19. Osteonecrosis of the jaw correlated to bisphosphonate therapy in non-oncologic patients: clinicopathological features of 24 patients.
    Favia G, Pilolli GP, Maiorano E.
    J Rheumatol; 2009 Dec 15; 36(12):2780-7. PubMed ID: 19884275
    [Abstract] [Full Text] [Related]

  • 20. [Bisphosphonates-associated osteonecrosis of the jaw: review on reported cases].
    Gering A, Grange L, Villier C, Woeller A, Mallaret M.
    Therapie; 2007 Dec 15; 62(1):49-54. PubMed ID: 17374348
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.